Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System In the Treatment of Subacute and Chronic Subdural HEmatoma (EMBOLISE)

NCT04402632 is registered in ClinicalTrials.gov with Medtronic Neurovascular Clinical Affairs as lead sponsor.

NCT NCT04402632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04402632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System In the Treatment of Subacute and Chronic Subdural HEmatoma (EMBOLISE)
Lead sponsor
Medtronic Neurovascular Clinical Affairs
Phase
Not applicable
Overall status
Completed
Start date
October 27, 2020
Completion date
April 3, 2025
Enrollment
600 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

subdural hematoma